BPC 157: The Promise and Perils of a Healing Peptide: Apple, Alex: 9798319471673: Amazon.com: Books In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for FDA moves toward easing restrictions on certain peptides BioPharma Dive How much BAC water? : r Retatrutide Peptides may soon be easier to get amid RFK Jr.'s push, but experts warn of risks Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences